NYSE:CO Global Cord Blood (CO) Stock Forecast, Price & News $1.23 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$1.23▼$1.2350-Day Range$0.90▼$1.8452-Week Range$2.03▼$5.50Volume118 shsAverage Volume216,519 shsMarket Capitalization$149.51 millionP/E Ratio1.92Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Global Cord Blood (NYSE:CO) StockGlobal Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More CO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CO Stock News HeadlinesSeptember 19, 2023 | markets.businessinsider.comONWARD® Reports 2023 Half Year Results and Business UpdateSeptember 18, 2023 | msn.comSpinal fluid test may enable earlier diagnosis of Parkinson's diseaseSeptember 24, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.September 17, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)September 15, 2023 | benzinga.comCord Blood Banking Services Market Size is projected to reach USD 5.37 Billion by 2031, growing at a CAGR of 13.8%: Straits ResearchAugust 29, 2023 | businesswire.comGlobal Blood & Plasma Components Market Outlook 2023-2027 with Revenue Shares by Product, Application, End-user and Company - ResearchAndMarkets.comAugust 28, 2023 | businesswire.comGlobal Cord Blood & Tissue Banking Industry Report 2023: Cord Blood Market Dominated by Top 12 Banking Operators, Accounting for Over 70% Control - ResearchAndMarkets.comAugust 24, 2023 | finance.yahoo.comGlobal Cord Blood & Tissue Banking Industry Report 2023 - Industry Witnesses Robust Consolidation as Investor Demand SurgesSeptember 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 16, 2023 | finance.yahoo.comGLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032August 1, 2023 | finance.yahoo.comGlobal Stem Cell Banking Market to Reach $14.3 Billion by 2030: Adult Stem Cell Research Gains Traction, Accelerating Research FundingJuly 28, 2023 | benzinga.comChrissy Teigen Selects Cord Blood Registry® to Preserve Fourth Child's Newborn Stem CellsJuly 27, 2023 | benzinga.comNational Marrow Donor Program® (NMDP)/Be The Match® Names Christina Melief, Ph.D., Senior Scientific AdvisorJuly 25, 2023 | finance.yahoo.comHematopoietic Stem Cell Transplantation Global Market Report 2023July 10, 2023 | finance.yahoo.comBe The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank AllianceJuly 10, 2023 | benzinga.comBlood Market to grow by USD 2,195.69 million from 2022-2027|Rising number of hospitals and blood banks to boost the market- TechnavioJune 21, 2023 | morningstar.comGlobal Cord Blood Corp Shs Stock SettlementJune 16, 2023 | msn.comDisused Avon Campus In Rye To Get New Life Through NY Blood CenterJune 9, 2023 | uk.finance.yahoo.comGlobal Cell Isolation/Cell Separation Market Report 2023: Growing Focus on Personalized Medicine Fuels the SectorJune 9, 2023 | finance.yahoo.comBone Marrow Transplantation Global Market Report 2023June 7, 2023 | markets.businessinsider.comMAK-System partners with New York Blood Centre EnterprisesJune 7, 2023 | technews.tmcnet.comNYSE to Commence Delisting Proceedings Against Global Cord Blood Corporation (CO)June 5, 2023 | benzinga.comBlood Thawing System Market Poised to Reach USD 400 Mn by 2030, Driven by 7.3% CAGR: TMR StudyJune 1, 2023 | msn.comCompanies Knew the Dangers of PFAS 'Forever Chemicals'—and Kept Them SecretJune 1, 2023 | finance.yahoo.comCell Therapy Global Market to Grow Rapidly at a CAGR of ~14% by 2028 | DelveInsightMay 31, 2023 | finance.yahoo.comGlobal Biobanking Market Report 2023: Focus on Genetic Testing and Precision Medicine Drives GrowthMay 31, 2023 | finance.yahoo.comGlobal Allogeneic Cell Therapy Market to 2030: Increasing FDA Approvals of Allogeneic Cell Therapies Drives GrowthSee More Headlines Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Company Calendar Last Earnings6/26/2018Today9/24/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.92 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.12 Cash Flow$0.29 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.19Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$149.51 million OptionableOptionable Beta0.16 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey CompetitorsViemed HealthcareNASDAQ:VMD111NASDAQ:YIGossamer BioNASDAQ:GOSSTaysha Gene TherapiesNASDAQ:TSHAAstria TherapeuticsNASDAQ:ATXSView All Competitors CO Stock - Frequently Asked Questions How have CO shares performed in 2023? Global Cord Blood's stock was trading at $2.9876 on January 1st, 2023. Since then, CO stock has decreased by 58.8% and is now trading at $1.23. View the best growth stocks for 2023 here. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) released its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Is Global Cord Blood a good dividend stock? Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CO. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $1.23. How much money does Global Cord Blood make? Global Cord Blood (NYSE:CO) has a market capitalization of $149.51 million and generates $1.24 billion in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis. How many employees does Global Cord Blood have? The company employs 1,202 workers across the globe. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181. This page (NYSE:CO) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.